AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data. Now, Vyalev (foscarbidopa and ...
The biggest stories of the day delivered to your inbox.
Tutorials on real-time analysis and forecasting for outbreak analytics with R developed by the Epiverse-TRACE initiative. These tutorials are visible at: https ...
Here's all you need to know about sleep disorders, irregular sleep schedules, insomnia, when to see a specialist, and more.
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results